In some recent merger cases, shareholder plaintiffs have based their suits on the claim, among others, that the venture capitalists on the board who constituted a majority had conspired to sell the company at a discount to the detriment of minority shareholders. Venture capitalists aren’t often accused of undue generosity, but especially not to buyers. San Diego-based Trius Therapeutics, which was sold to Cubist Pharmaceuticals well over a year ago, was sued in both Delaware and California. Though the suit was dismissed in Delaware, the case grinds on in California.